Home > Boards > US OTC > Miscellaneous > Enzolytics Inc. (ENZC)

Why $ENZC is the future Big Pharma and

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
UncleBilly Member Profile
 
Followed By 84
Posts 338
Boards Moderated 0
Alias Born 06/20/20
160x600 placeholder
CEO Presenting on the Emerging Growth Conference on October 13 Register Now InvestorsHub NewsWire - 10/12/2021 7:00:00 AM
CLIS - ClickStream Corp Sees User Growth For Its HeyPal™App Surge, Launch On Android In November Could Create Substantially More Interest InvestorsHub NewsWire - 10/11/2021 10:24:20 AM
CEO Presenting on the Emerging Growth Conference on Tomorrow.  Register Now InvestorsHub NewsWire - 8/17/2021 7:00:00 AM
CEO Presenting on the Emerging Growth Conference on August 4.  Register Now InvestorsHub NewsWire - 8/2/2021 8:27:01 AM
CLIS - ClickStream's HeyPal(TM) App Experiencing Explosive Growth by Reaching Over 3,000,000 Messages, 650,000 Translations, 140,000 Likes, 17,000 Posts and 86,000 Downloads in Just Over 5.5 Months of Beta Launch InvestorsHub NewsWire - 7/28/2021 12:17:04 PM
ALYI Signals VERY BULLISH InvestorsHub NewsWire - 7/23/2021 9:47:41 AM
Enzolytics and Lonza Bioscience ink collaboration agreement Seeking Alpha - 7/21/2021 8:08:36 AM
CEO Presenting on the Emerging Growth / Investors Hub Joint Conference Today! Register Now Niche Companies in Technology, InvestorsHub NewsWire - 7/7/2021 7:00:00 AM
Solar Industry Rollup Continues: Solar Integrated Roofing (SIRC) Targets $100+ Million for 2022, Continues Acquisitions InvestorsHub NewsWire - 6/23/2021 9:16:37 AM
CLS Holdings, (OTCQB: CLSH) $1.9 million Net Revenue for May 87% Increase InvestorsHub NewsWire - 6/15/2021 8:27:38 AM
WNRS Strikes Deal With RSI InvestorsHub NewsWire - 6/14/2021 10:26:26 AM
Enzolytics partners with Intel to co-author a white paper on use of AI in healthcare Seeking Alpha - 5/17/2021 9:53:43 AM
The Emerging Growth Conference is Today April 14 Register now - CEO's Presenting InvestorsHub NewsWire - 4/14/2021 6:30:00 AM
CEO's Presenting on the Emerging Growth Conference on April 14.  Register now. InvestorsHub NewsWire - 4/13/2021 8:18:50 AM
CEO's Presenting on the Emerging Growth Conference on April 14.  Register now. InvestorsHub NewsWire - 4/12/2021 6:47:25 AM
Epazz, Inc. (OTC Pink: EPAZ) Drone Video Release now Live InvestorsHub NewsWire - 3/25/2021 6:00:00 AM
CLS Holdings, (OTCQB: CLSH) $1.49 million Net Revenue for Feb Highest in Company History InvestorsHub NewsWire - 3/9/2021 6:37:33 AM
CLS Holdings, (OTCQB: CLSH) Record January NET Revenue of $1.48 Million Beating Target InvestorsHub NewsWire - 2/9/2021 6:48:48 AM
CLS Holdings, (OTCQB: CLSH) $17 million Sales, 60% Growth & 5 New Products InvestorsHub NewsWire - 2/2/2021 6:52:54 AM
WSGF's, Vaycaychella, Heats Up In $32 Billion Caribbean Vacation Market; Adds Six-Room Hotel To Portfolio Interests InvestorsHub NewsWire - 1/22/2021 9:48:20 AM
UncleBilly   Sunday, 10/04/20 12:30:10 PM
Re: suny66 post# 27298
Post # of 139657 
Why $ENZC is the future Big Pharma and Monoclonal Antibodies are the FUTURE of Medical Care: (this is very big; please sticky if you deem worthy)

Different types of monoclonal antibodies treat different types of diseases.

Just last week, a BOMBSHELL report came out from Gates Foundation affiliate "WELLCOME" called "Expanding Access to Monoclonal Antibody-Based Products: A Global Call to Action"

In a nutshell, MONOCLONAL ANTIBODY treatments are the FUTURE of medical care because they provide superior results without toxic side effects of Big Pharma's pharmaceuticals. They basically use your own body to heal itself organically without toxic side effects.

All sources, including the report and very interesting case studies can be found in this DD thread on Twitter. KNOW WHAT YOU HOLD! This is the future:

https://twitter.com/UncleBillyMoney/status/1312595840637300736?s=20

Dr. Cotropia is clearly a pioneer in monoclonal antibodies discovery dating back prior to 1989. He's been there from the beginning and now is his time as commercial access is finally being granted as Big Pharma is spread thin and can no longer fight the advancement of what President Trump called "miracle treatments sent down from God" just last night (10/3/20).

There are big issues at play here.

The efficacy and commercial viability of monoclonal antibodies has been known for some time but mass commercial use would have upset Big Pharma's profits because monoclonal antibodies treatments would have replaced some of their cash cow pharmaceuticals in their pipeline.

Note, BioClonetics is in late stages with HIV treatments but they also have several other treatments in the pipeline (see below). This could genuinely be the next Big Pharma, replacing antiquated special interests that do not always serve the health and needs of the people. Current Big Pharma views us as customers, rather than patients; monoclonal antibody treatments will usher in a new era and revolutionize medical care and there will be big winners in this space. $ENZC will be one of them. Get ready.

"BioClonetics is a company with proprietary technology for producing fully human monoclonal antibodies (mAbs) against infectious diseases including HIV, rabies, influenza A, influenza B, tetanus, and diphtheria. BioClonetics proprietary methodology for producing fully human MONOCLONAL ANTIBODIES may be used to produce therapeutic fully human MONOCLONAL ANTIBODIES for treating many infectious diseases including the #Coronavirus""

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences